Plain-English translation of NCT07028372 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a follow-up study for people who survived cardiac arrest and received ultra-rapid cooling treatment (using a device called Vent2Cool) as part of the OverCool clinical trial. Researchers want to track how these survivors are doing months and years after their treatment to understand the long-term effects of this new rapid cooling approach.
Cardiac arrest is life-threatening, and even when patients are revived by emergency responders, they often suffer serious brain and organ damage. This new rapid cooling method shows promise in protecting the brain and heart if applied very quickly after resuscitation. This follow-up study will help doctors understand whether the benefits of rapid cooling continue long after treatment.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to check in on your health status and recovery after your cardiac arrest and cooling treatment. This is a non-interventional study, meaning you won't receive new treatments—researchers will simply follow up with you (or a family member or trusted person) to understand how you're doing long-term. The study tracks survivors who already completed the initial OverCool trial to learn about their ongoing outcomes.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France